Never miss an update from iBio. Did you know that during reporting season, the announcements from NYSEMKT:IBIO often move the market?
|52w High/Low:||$0.05 - 7.45|
|Volume/Average:||3.1M - 10.8M|
Here's what it would take. Keith Speights Popularity isn't necessarily a good thing. There have been plenty of popular stocks in the past that eventually flamed out.But popularity isn't necessarily a bad thing, either. For example, quite a few of ...Why iBio Stock Is Soaring Today
The company is advancing its most-promising vaccine candidate for the novel coronavirus. Prosper Junior Bakiny Shares of iBio (NYSEMKT:IBIO) were up by 6.8% as of 11:38 a.m. EDT after climbing by as much as 19.5% earlier today, following the compa...Why iBio Stock Jumped Today
The biotech struck a licensing deal for a potential coronavirus treatment. Joe Tenebruso Shares of iBio (NYSEMKT:IBIO) climbed on Friday after the biologics manufacturer announced an exclusive global license agreement with Planet Biotechnology for...These 5 Healthcare Stocks Are the Biggest Winners in 2020
It's not a surprise that all five of these stocks are engaged in the fight against the novel coronavirus. Taylor Carmichael Plenty of healthcare stocks are faltering this year. Some companies are struggling to get their products in front of patien...Why ADMA Biologics, iBio, and Kamada Are Jumping Today
The FDA's emergency use authorization of convalescent plasma therapy is sending these three stocks higher today. George Budwell At a news conference Sunday, President Donald Trump announced that the Food and Drug Administration issued an emergency...Why Novavax, Vaxart, Sorrento Therapeutics, and Other Coronavirus Stocks Plummeted Today
Major new developments in the race for a COVID-19 vaccine are driving investors to reevaluate their positions. Joe Tenebruso Coronavirus-related stocks declined sharply on Wednesday, extending their losses following Russia's announcement on Tuesda...Better Coronavirus Stock: iBio vs. Vaxart
These two small-cap biotech stocks have intriguing COVID-19 vaccine candidates. Keith Speights iBio Pharma (NYSEMKT:IBIO) and Vaxart (NASDAQ:VXRT) rank as two of the biggest winners so far this year among small-cap biotechs with coronavirus progra...